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1 
The Problem 
 Many Vermonters are familiar with 
the term “Beaver Fever” and its 
association with illness after 
drinking from streams, ponds, 
lakes, or other untreated water 
sources.  
 “Beaver Fever,” or Giardiasis, is 
caused by a single-celled parasite 
called Giardia intestinalis.  Giardia 
is found in every state in the 
United States and is the most 
commonly identified intestinal 





The Problem, cont.  
 According to the most recent reports by the CDC, Vermont consistently has 
the highest rate of Giardia infection in the nation and has an incidence rate 
(number of new infections in the population at a given time) that is 
approximately three times higher than that of Maine, the state that ranks 
second in Giardia infection. 
 Since the risk of infection for Vermonters                                                              
is so high, it is important for both patients                                                        
and providers to understand the                                                                
transmission, symptoms, and treatment of                                                          
this very common disease. 
 The Health Center, Plainfield, VT, has                                                            
identified Giardiasis as a topic of interest                                                               
as the providers frequently encounter 




2012 Incidence Rate of Giardiasis 
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Public Health Costs 
 There are many public health costs associated with Giardia infection that could 
be reduced with more patient and provider education 
 Cost of annual hospitalizations – Estimated $16-63 million annually  
 Cost of medication for treatment of Giardiasis  
 Cost of laboratory testing and resources for Giardiasis 
 Cost of increased number of physician appointments 
 
 There are many Indirect Costs / Considerations: 
 Patients with Giardiasis often have to miss numerous work days 
 Younger patients may need to miss school due to illness 
 One infected individual can potentially transmit Giardia to numerous 
others, thus increasing overall healthcare costs, if not managed 
 Since Giardiasis can mimic, or even cause, diseases like irritable bowel 
syndrome, peptic ulcer disease, reactive arthritis, and even some types of 
cancer, there may be unnecessary healthcare and societal related expenses 
3 
Community Perspective 
 “Many of my patients have non-specific gastrointestinal symptoms and certainly 
have giardiasis due to living in Vermont, where it is extremely common” – Melissa 
Houser, MD. The Health Center 
 “The Health Center providers could benefit from a more definitive protocol to 
address empiric treatment of Giardia in varied gastrointestinal presentations. 
Research and review of this matter  would clarify the widespread use of medications 
like Tindamax for symptoms that overlap with IBS, GERD, and other diarrheal 
diseases” – Jessica Fisch, PA-C. The Health Center 
 “I feel there is a definite need for patient education about Giardia infection.  
Anything that will help patients recognize the symptoms of Giardiasis and avoid 
initial infection would be invaluable”  - Emma Kopecky, NP. The Health Center  
 “Because it is transmitted via the fecal-oral route, Giardia can be easily spread not 
only through personal contact, but via contaminated water  where cysts can survive 
for up to three months. This is an especially important mode of transmission in 
Vermont where people who enjoy the outdoors may come into contact with water 
contaminated by infected wildlife.” – Maeghan O’Neill, PhD. Institute of 
Parasitology, McGill University 
4 
Intervention & Methodology  
 Providers at The Health Center identified a 
lack of knowledge and informational 
resources available to the community about 
Giardiasis.  
 Created and distributed an 
informational brochure that can be used 
in waiting rooms or when discussing 
Giardiasis with patients (Shown to right) 
 Submitted news articles to two 
newspapers (The World and The Times 
Argus) that are distributed throughout 
the Central Vermont community served 
by The Health Center 
5A 
Intervention & Methodology, cont. 
 Providers expressed an interest in 
learning more about Giardiasis due 
to the large number of patients they 
treat for this parasitic infection.  
 Provided an oral presentation 
and informational handout 
about Giardiasis (shown to right) 
to physicians, physician 
assistants, nurse practitioners, 
nurses, and support staff at The 
Health Center following a 
thorough literature review, 
discussion with representatives 
at the Institute of Parasitology 
(McGill University), CDC, and 
Vermont Department of Health 
 
5B 
Results & Response  
 Providers and staff at The Health Center responded very positively to the session 
focused on provider education regarding Giardiasis in Vermont and to both the 
provider and community resources that originated from this project 
 Many of the providers indicated that they found the material presented to be “extremely 
relevant” to their practice 
 Many providers stated the presentation included “information that they otherwise would 
not have known” 
 One provider stated: “This presentation greatly helped the practice come to consensus 
about treatment approach to Giardiasis and was extremely helpful overall!”  
 An informational brochure is available to patients in the waiting area of The Health 
Center, as well as in electronic format for use by providers when discussing 
Giardiasis with patients 
 A one page quick-reference handout was provided to all providers to enhance 
knowledge related to Giardia, its prevalence in Vermont, symptoms, testing 
modalities, and most up-to-date suggestions for treatment 
 An educational article was submitted to two local newspapers. At the time of this 
project’s conclusion, The Times Argus published the article “Beaver Fever--
Giardiasis in Vermont” in the April 22, 2017 edition. The World newspaper 
indicated that they would be publishing the informational article about Giardiasis 
in the May 3rd, 2017 edition to promote further awareness in the community 
6 
Evaluation of Effectiveness  
 Effectiveness 
 The goals of this project to promote public and provider awareness about 
Giardiasis in Vermont was successfully achieved by providing a handout and 
oral presentation to providers, and an educational brochure and newspaper 
awareness publication to the patient population 
 The primary method for evaluating patient awareness of Giardiasis will be 
determined by providers going forward. It can be gauged by the level of 
knowledge in the patient population, if the topic comes up, and also by seeing 
if patients bring more questions related to Giardia to their provider 
 Limitations  
 The assessment of effectiveness for educating the community about 
Giardiasis will need to be evaluated over time as people have the opportunity 
to see the educational resources (brochures and newspaper articles) 
 The time constraints of this family medicine rotation do not allow for patient 




 Assess provider perspectives to see if they believe patient awareness of 
Giardiasis has been enhanced in the patient population of The Health 
Center 
 Survey patients for their perspective and perceived knowledge after 
educational resources have been available for a given period of time 
 Enhanced community outreach could include radio and web-based 
information, as well as education at local schools and public events 
 Encourage offices and providers to identify patients at risk for exposure to 
Giardia, either by age, occupation, or outdoor activity, and discuss 
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